WO2019052830A1 - METHODS FOR ISOLATING AN EXTRACT OF CANNABINOID AND A PRODUCT FROM CANNABIS PLANT MATERIAL - Google Patents

METHODS FOR ISOLATING AN EXTRACT OF CANNABINOID AND A PRODUCT FROM CANNABIS PLANT MATERIAL Download PDF

Info

Publication number
WO2019052830A1
WO2019052830A1 PCT/EP2018/073392 EP2018073392W WO2019052830A1 WO 2019052830 A1 WO2019052830 A1 WO 2019052830A1 EP 2018073392 W EP2018073392 W EP 2018073392W WO 2019052830 A1 WO2019052830 A1 WO 2019052830A1
Authority
WO
WIPO (PCT)
Prior art keywords
cannabinoids
dispersion
phase
cannabinoid
oil
Prior art date
Application number
PCT/EP2018/073392
Other languages
English (en)
French (fr)
Inventor
Albert Jan Dijkstra
Original Assignee
Albert Jan Dijkstra
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Albert Jan Dijkstra filed Critical Albert Jan Dijkstra
Priority to CA3075323A priority Critical patent/CA3075323A1/en
Publication of WO2019052830A1 publication Critical patent/WO2019052830A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78Ring systems having three or more relevant rings
    • C07D311/80Dibenzopyrans; Hydrogenated dibenzopyrans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D11/00Solvent extraction
    • B01D11/02Solvent extraction of solids
    • B01D11/0288Applications, solvents
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D11/00Solvent extraction
    • B01D11/02Solvent extraction of solids
    • B01D11/0292Treatment of the solvent
    • B01D11/0296Condensation of solvent vapours
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine

Definitions

  • the present invention relates to processes for obtaining a cannabinoid extract and product from Cannabis plant material.
  • a high purity A 9 -tetrahydrocannabinol (THC) isolate is produced from a crude solvent extract by subjecting this extract to thin film evaporation, chromatographically fractionating the refined extract to obtain high purity fractions and subjecting the high purity fractions to another thin film evaporation.
  • THC tetrahydrocannabinol
  • the organic extract is extracted with an aqueous base and subsequently, multiple extractions with tert -butyl methyl ether, washing with water, extraction with pentane, treatment of the pentane miscella with activated carbon are necessary to arrive at a purified A 9 -tetrahydrocannabinol product. It uses large amounts of solvents and thereby generates large amounts of waste and effluents.
  • WO 2017/026897 Al discloses a laboratory extractor for contacting marihuana with the extraction solvent ethanol.
  • US Patent Application Publication US 2017/0008870 discloses a process to extract marihuana with a solvent and cooling the solvent extract so that a precipitate is formed and removing the precipitate by filtration. By further cooling to temperatures as low as -50°C or even - 85°C, a cannabinoid precipitate is formed that is collected.
  • two 300 mL cans of butane are used to extract only 50 g of Cannabis plant material which may contain only 5 g of cannabinoids , which makes it an expensive process.
  • cannabinoids are volatilized by contacting the Cannabis plant material with a gas that has been heated to a temperature above 100°C that is sufficiently high to volatilize at least one cannabinoid but not so high as to cause pyrolysis of the Cannabis plant material, and condensing the vapour and collecting the condensate.
  • the inventor has surprisingly found that the disadvantages of the prior art methods can be overcome by a process for obtaining a cannabinoid extract from Cannabis plant material wherein plant material comprising cannabinoids derived from one or more Cannabis plants is first suspended in an oil before isolation of the cannabinoids from said oil.
  • the invention relates to a process for obtaining a cannabinoid extract from Cannabis plant material comprising the steps of:
  • the invention in a second aspect, relates to a process for obtaining a cannabinoid product, comprising the steps of obtaining a cannabinoid extract in accordance with the first aspect of the invention; and adding one or more flavours or aromas to said extract.
  • the present invention is based on the finding that when in a process for obtaining a cannabinoid extract from Cannabis plant material, Cannabis plant derived material is first dispersed in an oil before isolation of the cannabinoids contained therein, these cannabinoids can be isolated in a way that produces higher yields than prior art methods.
  • the process of the invention leads to almost pure cannabinoids.
  • the process of the invention can be carried out easily on a large scale in an economically advantageous manner.
  • Cannabis plant derived material is used as raw material for the isolation of cannabinoids.
  • This Cannabis plant derived material may encompass whole plants but preferably parts thereof that contain the principal medically or recreationally active ingredients, for example the aerial parts of the plant or isolated leaves, stems or flowering heads with the trichomes containing most of the cannabinoids.
  • Cannabis plant material may be freshly harvested plant material or dried material.
  • the water content of the raw material is immaterial since this water will be removed during said process anyway.
  • cannabis plant material has already been subjected to a partial extraction before being treated in the process of the invention.
  • the term “Cannabis plant derived material” may also relate to plant parts as well as mixtures of compounds derived from Cannabis plants that still need further purification of the cannabinoids contained therein.
  • the term "dispersion” as referred to in the present invention may be a solution or a suspension.
  • the terms "suspension” and “slurry” have the same meaning and are used interchangeably. Therefore the dispersion may be in the form of a solution containing cannabinoids and other compounds.
  • a solution may be prepared from a marihuana extract that has been purchased externally and has been produced by extracting Cannabis plant material, for instance with a non-polar solvent such as butane or carbon dioxide, and that requires purification according to the process of the invention because it contains one or more non-cannabinoid impurities like waxes and colouring compounds .
  • the dispersion is in the form of a suspension containing Cannabis plant pieces.
  • plant pieces are suitably larger than 0,1 mm in at least one of their dimension and encompass plants or plant parts, for instance ground plant material or plant material that is chopped into pieces.
  • the chopped material may then be fed into a slurry vessel to form a suspension.
  • this slurry vessel may be the same vessel as the one used during extraction.
  • the vessel may be provided with a mechanical disperser, the purpose of which is to finely divide the plant material so that the access of the solvent to the cannabinoids and their rate of dissolution are improved.
  • the access of the oil can also be improved by applying ultrasonics or a pulsed electric field to the slurry vessel during at least part of the dispersing stage .
  • annabinoids is meant to refer to compounds derived from Cannabis plants that act on cannabinoid receptors in cells that alter neurotransmitter release in the brain. These cannabinoids are concentrated in the trichomes of the plants.
  • Non-limiting examples of cannabinoids in the context of the invention include tetrahydrocannabinol, cannabidiol, cannabinol, cannabigerol , cannabichromene, cannabicyclol , cannabivarin, tetrahydrocannabivarin, cannabidivarin, cannabichromevarin, cannabigerovarin, cannabigerol monomethyl ether, cannabielsoin, cannabicitran and their carboxylic acids. Accordingly, in the method of the invention at least one of the cannabinoids selected from this group is isolated from the oily dispersion in step b) .
  • the cannabinoid extract contains at least tetrahydrocannabinol, in particular A 9 -tetrahydrocan- nabinol. Accordingly, preferably fractions containing at least A 9 -tetrahydrocannabinol are taken to prepare the cannabinoid extract. Such fractions preferably contain ⁇ 9 - tetrahydrocannabinol in high purity.
  • oil is meant any nonpolar chemical substance that is a viscous liquid at ambient temperatures and is both hydrophobic and lipophilic.
  • a preferred oil for purposes of this invention is a vegetable oil. Suitable examples of such vegetable oils are soybean oil, rapeseed oil, corn germ oil or sunflower seed oil, but more exotic oils such as hemp seed oil can also be used in the process according to the invention.
  • cannabis oil itself for purposes of dispersing material comprising cannabinoids derived from one or more Cannabis plants in it, but for commercial reasons it is preferred not to use cannabis oil.
  • the oil to be used has preferably a low polyunsaturated fatty acid content and for ease of handling, it preferably has a low saturated fatty acid content. Accordingly, a high oleic sunflower seed oil is considered to be highly suitable for the process according to the invention.
  • mineral oils can suitably be used.
  • An example is medicinal liquid paraffin, also known as paraffinum liquidum.
  • oils contain one or more antioxidants
  • the liquid paraffin does not. Therefore, in such a case it is preferred that one or more antioxidants are added to the oil to protect the cannabinoids against oxidation.
  • antioxidants should not be volatilized during the subsequent vacuum stripping process so butylated hydroxytoluene (BHT) is less suitable because of its volatility. Propyl gallates are less volatile and are therefore preferred.
  • BHT butylated hydroxytoluene
  • some volatile antioxidant may be added in conjunction with a non ⁇ volatile antioxidant to protect the condensate against oxidation .
  • the plant material it is preferred to add the plant material gradually to the oil.
  • properties of the suspension such as solids content and viscosity can be accurately controlled.
  • the suspension strength and its cannabinoid content are preferably as high as possible given the handling constraints of the processing equipment. For this reason, it may be advantageous to heat the suspension while it is being prepared for instance by using a jacketed vessel or internal heating coils.
  • the oil to be introduced into a slurry vessel may vary in temperature and for this reason, the possibility to control the temperature of the vessel contents allows a constant final suspension temperature to be attained.
  • isolation of the cannabinoids from the oily dispersion comprises one or both of
  • the isolation of cannabinoids from the oily suspension can be suitably carried out by the use of a gaseous stripping medium or by the use of a polar solvent. Therefore, in one embodiment in the process according to the invention the isolation comprises treatment of said dispersion with a gaseous stripping medium or a polar solvent, to isolate at least a portion of said cannabinoids from said dispersion into said gaseous stripping medium or said polar solvent .
  • suitable fractions are extracted and collected.
  • the inventor has observed that various fractions may be obtained, among which fractions containing terpenes, fractions containing compounds that adversely influence taste, smell and/or appearance or other compounds that are of no use in a cannabinoid product, and fractions that contain cannabinoids. From the latter fractions, suitable fractions are isolated and optionally concentrated to provide a cannabinoid extract. Suitable fractions contain high purity of one or more cannabinoids .
  • a vacuum stripping process is used to extract the cannabinoids from the oil to isolate the cannabinoids. It has been found that this embodiment is in particular suitable for isolating cannabinoids from crude cannabinoid plant material such as a dispersion in the form of a suspension containing parts of plants, such as chopped pieces of plants.
  • step b) comprises: stripping the dispersion under reduced pressure with a gaseous stripping medium to extract said cannabinoids from said dispersion into said gaseous stripping medium to obtain a vapour containing cannabinoids; condensing at least part of said vapour to form a condensate; and recovering said cannabinoid extract from said condensate.
  • the oil is preferably stripped under vacuum before being used in the process according to the invention to prevent malodorous compounds present in the oil being removed and condensed at the same time as the cannabinoids .
  • the vacuum stripping treatment will not only remove the cannabinoids from the dispersion but all compounds that are volatile under the stripping conditions in force. Accordingly, any water present in the dispersion will be removed, which is why the water content of the Cannabis plant material used in the process according to the invention is of no significance, and the Cannabis plant material need not be dried.
  • the vapour pressures of the individual cannabinoids differ, so during vacuum stripping there will be some preferential evaporation. Consequently, the composition of the condensate will not be identical to the cannabinoid composition of the crude plant material.
  • the cannabinoid composition of the condensate may vary in time. Early condensates will be enriched in the most volatile cannabinoids but when their concentration in the oil decreases, so does their rate of volatilization and thus their concentration in the condensate.
  • Various stripping media can be used in the process of the invention but water vapour is preferred.
  • Water has a relative molecular mass of 18 so the amount to be used to attain a certain result is relatively small; besides, it is cheap and inert.
  • Nitrogen (relative molecular mass equals 28) can also be used but it has the disadvantage that it does not condense so that the vacuum pump system has to compress the entire stripping medium introduced into the stripping vessel to atmospheric.
  • Methanol has a relative molecular mass of 32 and has the advantage that at low temperatures, it will condense without solidifying. Accordingly, methanol can be advantageously used in continuous operations since it permits continuous removal of condensate from low-temperature condensing systems in which water would freeze; moreover, cannabinoids are fairly soluble in methanol.
  • the stripping medium can be introduced into the stripping vessel in a number of ways. In large continuous installations one suitable way is to use mammoth pumps. They ensure a good contact between the stripping medium and the oil and are the preferred equipment for large installations. Smaller installations can use a hollow ring with holes along its circumference below the surface of the liquid.
  • the oil is preferably heated. It is preferred to maintain the temperature of said oil below 250°C, more preferably up to a maximum of 240°C in order to prevent release of bad odours. This affects the amount of stripping medium required to remove the cannabinoids from the dispersion and thus the period of time during which the dispersion is stripped at its final temperature. This period of time also affects the decarboxylation of the cannabinoic acids, which is important to render the cannabinoids in their psychomimetically active form. Decarboxylation of for instance A 9 -tetrahydrocannabinolic acid results in the psychomimetically active form A 9 -tetrahydrocannabinol .
  • the periods of time and the temperatures used in the process according to the invention will suffice to ensure a sufficient degree of decarboxylation of cannabinoic acids present in the dispersion but if this turns out to require a further heat treatment, this can be provided by extending the period of time the dispersion is held at the final stripping temperature.
  • the dispersion is vacuum stripped by sparging vapour, such as water vapour, while its temperature is gradually increased.
  • the dispersion may in a first step be heated to 100°C at which a light fraction of terpenes including pinene, limonene, myrcene and linolool are stripped from the oil.
  • a further fraction comprising the heavier sesquiterpenes such as caryophyllene, humulene and valencene are stripped from the oil.
  • the cannabinoic acids decarboxylate and carbon dioxide is liberated.
  • the temperature can then be further raised to about 200°C to extract further material.
  • cannabinoids can then be extracted from the oily dispersion.
  • the presence of terpenes influences the aroma and flavour of cannabis products.
  • the cannabinoid fraction (s) may be recombined with one or more of the terpene fractions depending on the desired aroma and flavour profile of the cannabinoid product.
  • the pressure is maintained below 20 mbar absolute, preferably below 10 mbar absolute, and more preferably below 5 mbar absolute.
  • Maintaining the vacuum in the stripping vessel requires one or more vacuum pumps.
  • steam ejector batteries with interspersed condensers can be used for this purpose, whereby these volatiles are condensed by the cooling water condensing the motive steam, or they can be condensed in a separate scrubber.
  • these condensation processes are more focused on removal of volatiles than on isolating these volatiles in as pure a state as possible. Consequently, the process according to the invention preferably employs mechanical vacuum pumps in combination with surface condensers .
  • the vapour containing said cannabinoids that is obtained during the stripping step is compressed before being at least partially condensed.
  • the pump nearest to the stripping vessel can be a Roots blower that compresses the vapour leaving the vessel to some 50 mbar and thus maintains a pressure of 3- 5 mbar absolute in said stripping vessel.
  • this vapour is passed along a surface condenser that is cooled by liquid ammonia, all volatiles including the water if used as stripping medium will condense and solidify so that a relatively small pump can be used to maintain the vacuum in the condensing section; a small water ring pump can be used for this purpose.
  • the process according to the invention is not limited to these types of pumps that have only been mentioned by way of illustration.
  • a preferred embodiment of the process according to the invention therefore comprises two or more low temperature surface condensers in series that permit successive isolation of the various fractions. If these fractions are solid at the condenser temperature, it may be advantageous to install two condensers in parallel and switch from one condenser to the other while thawing, emptying and preparing the original one.
  • Maintaining the temperature of the surface condensers at a temperature at which the water used in the vacuum stripping treatment will freeze requires a coolant like liquid ammonia or a glycol/water mixture. Refrigeration plants that will ensure the low temperature are well-known and commonly available.
  • the final condensate consists primarily of water used as stripping medium and cannabinoids.
  • the latter do not dissolve in water so that melting and warming said condensate leads to a two phase system.
  • the lower phase consists of dirty water that is to be discarded and the upper phase consists of almost pure cannabinoids that can be isolated by sheer phase separation.
  • the stripping process may also be carried out continuously.
  • all volatile compounds are removed simultaneously but they can be collected separately by using two or more condensers in series whereby the first condenser that is reached by the vapour stream operates at a surface temperature at which the least volatile components of the vapour stream will condense selectively and the last condenser has a surface temperature that will cause the most volatile of the condensable components to condense or even freeze.
  • V s amount of volatiles before stripping (mol)
  • V e amount of volatiles after stripping (mol
  • the amount of stripping medium that is required to achieve a certain extent of volatile removal is proportional to the amount of oil being processed. It is also proportional to the system pressure but since the volume occupied by the stripping medium is inversely proportional to the system pressure, it follows that the extent of the volatile removal is really determined by the volume of the stripping medium. Because of the low system pressure, this volume is very large in comparison with the amount of oil being treated.
  • the amount of stripping medium is inversely proportional to the vapour pressure of the volatile compound. Since this vapour pressure increases with temperature, this means that less stripping medium is required to achieve the same extent of volatile removal when the temperature of the oil being stripped is increased.
  • the stripping medium requirement also depends on the equipment being used. If this ensures a good contact between stripping medium and the oil being stripped and if reflux of condensed vapours into the oil is prevented, the evaporation efficiency will be close to unity .
  • the stripping medium requirement is proportional to the logarithm of the ratio of the volatiles content before and after the stripping treatment. So if a certain amount of stripping medium suffices to half the volatile content, using the same amount again will also half the residual volatiles so that a quarter of the original amount is left. This means that whatever the amount of stripping medium used, there will always be some volatile compound left in the oil.
  • the vacuum stripping process differs fundamentally from a steam distillation process.
  • the volatile compound is not dissolved but forms a separate phase and its rate of evaporation does not decrease until said separate phase has been evaporated .
  • the vacuum stripping process may be continued until the residual cannabinoid content of the dispersion has been reduced to such an extent that recuperating part of this residual content is more costly than the value of the recuperated cannabinoids . Nevertheless, sometimes the extraction process is not complete and a substantial amount of cannabinoids remains in the oil after vacuum stripping. A further treatment that extracts the remaining cannabinoids can then be carried out using a solvent extraction step using a polar solvent. Because extraction according to this embodiment is carried out at a lower temperature than the vacuum stripping extraction, this embodiment reduces the period of time that the Cannabis plant material has to be exposed to high temperatures and may thus affect the extent of decarboxylation of the cannabinoic acids.
  • the isolation of cannabinoids comprises mixing said dispersion with said polar solvent, and forming a two-phase system with a first phase of the oily dispersion and a second phase of said polar solvent, wherein at least part of the cannabinoids is extracted into the second phase. Subsequently, at least part of the second phase is isolated from the first phase and from this isolated second phase the extract is prepared.
  • This extraction can be carried out for instance if the cannabinoid concentration in the oil is still too high after the abovementioned extraction by means of vacuum stripping, but it is well possible to perform this extraction on any other dispersion described in this application, such as a suspension containing parts of plants, such as chopped pieces of plants.
  • the extraction is optionally followed by evaporating at least part of said polar solvent to obtain a cannabinoid containing evaporation residue.
  • This evaporation residue can be subjected to further steps of extracting and isolating the cannabinoids contained therein.
  • the polar solvent is a liquid solvent and is not or poorly miscible with the oil, i.e. upon mixing of the oil and the polar solvent no homogeneous mixture is formed.
  • Ethanol is an example of a solvent meeting these requirements since at ambient temperatures, the solubility of oil in ethanol is negligible, especially when the ethanol contains some water.
  • Aqueous isopropanol is another example of a suitable extraction solvent especially since its dissolving power can be controlled via its water content. However, care should be taken to maintain a specific density difference between the oil and the aqueous isopropanol.
  • Suitable solvents may be selected from the group consisting of methanol, ethanol, isopropanol, water and mixtures thereof. Ethanol can be suitably used as the polar solvent.
  • the extraction solvent i.e. said polar solvent as referred to in this application
  • care must be taken to avoid accumulation of unwanted plant constituents, and other compounds that dissolve in the solvent and that are not removed by vacuum stripping or thermal decomposition. If these compounds were to dissolve in the extraction solvent, they would be re-introduced in a slurry vessel via the evaporation residue and accumulate. Therefore, it may be preferred to alternate between different solvents in the course of time. In that case, the solvent that is used after an earlier used solvent may function as a purge for removing these unwanted plant constituents.
  • This liquid/liquid solvent extraction can be carried out in several ways known to those skilled in the art.
  • the use of a Kuhni agitated extraction column has been shown to be an effective manner to remove the cannabinoids from the dispersion.
  • Mixer-settler equipment can also be used for this purpose.
  • the extraction comprises a combination of said vacuum stripping step and said solvent extraction step because solvent extraction often leads to coloured products.
  • the isolation comprises stripping the oily dispersion under reduced pressure with a gaseous stripping medium to obtain a vapour containing cannabinoids and a dispersion with reduced cannabinoids content, and performing a further extraction on said dispersion with reduced cannabinoids content, which comprises treatment with a polar solvent thereby forming a two-phase system with a first phase of said dispersion and a second phase of said polar solvent, wherein at least part of the cannabinoids from the dispersion with reduced cannabinoids content is extracted into the second phase, isolating at least part of the second phase from the first phase and optionally evaporating at least part of said isolated second phase to obtain a cannabinoid containing evaporation residue.
  • miscella can be added to the dispersion of the abovement ioned step a) for further extraction in accordance with any of the embodiments described above.
  • the process may comprise the further steps of:
  • the vacuum stripping process can be interrupted when the cannabinoid content of the oil is still worth recuperating.
  • a reason for this interruption might be the development of undesirable off-flavours by the Cannabis plant material because of its exposure to high temperatures for a prolonged period of time.
  • the stripped oil still contains residual cannabinoids and is therefore preferably re-used in order that these residual cannabinoids remain in the system.
  • this stripped oil may be present in a suspension that still contains extracted plant material that is preferably removed from this oil by separating the suspension into a liquid and a solids fraction. This separation can be effected by filtration or centrifugation .
  • the resulting filtrate or supernatant is preferably used to prepare a new suspension batch so that the cannabinoids present in said liquid fraction can be extracted by vacuum stripping; the filter cake can eventually be discarded.
  • this cake retains some oil and the cannabinoids present in this oil would be lost when the cake is discarded. Accordingly, it may be advantageous to extract the filter cake to recover the cannabinoids.
  • the extraction of the filter cake of step d) can be carried out in several manners. It can be performed in situ by feeding the filtration equipment with the solvent and thereby rinsing the cake. It can also be performed by isolating the filter cake by opening the filter press and suspending this cake in the extraction solvent. The suspension is then sent to another filter which can be a filter press or be of a pressure leaf type. The solvent that now contains cannabinoids from the filter cake is then isolated from the cake. After step d) , the isolated filter cake extract is at least partially evaporated and the evaporation residue can be added to the slurry vessel or vacuum stripping vessel where it will dissolve in the oil and from where it will be removed by vacuum stripping.
  • the oil that is retained in the filter cake may act as a purge.
  • the cannabinoids are not the only compounds that are extracted. In fact, all lipophilic compounds will be extracted. Accordingly, waxes, phosphatides and acyl glycerides move into the oil and since they are not removed during the vacuum stripping process, they will accumulate in this oil. Accordingly, a purge is needed to prevent these lipophilic compounds from accumulating.
  • the oil that is retained in the filter cake can act as such a purge. It ensures that a dynamic equilibrium will be reached in which the amount of nonvolatile lipophilic compounds that leaves the system with the filter cake equals the amount that is introduced by the extraction of the next batch of plant material. In this respect it is preferred that between the abovementioned steps c) and d) steps are carried out of: cl) rinsing said filter cake with an amount of rinsing oil; and
  • the amount of rinsing oil is preferably about equal to the amount of oil that is retained by the cake.
  • the extraction of the filter cake with a solvent like ethanol also yields a solvent-wet filter cake residue. If this residue is positioned on the leaves of a pressure leaf filter, it is possible to remove the solvent by blowing the filter with live steam. The gases leaving the filter can be condensed and the solvent can be recovered by distillation. This system has the advantage that blowing the residue with steam eliminates a fire hazard.
  • the use of a pressure leaf filter may necessitate the use of a filter aid. If a filter press has been used and the cake has been rinsed with the extraction solvent, the cake will contain the possibly inflammable solvent. This cake may then be disposed of.
  • the extraction process may be continued until recuperating residual cannabinoids from the oily dispersion or filter cake is more costly than the residual cannabinoids are worth. Then the depleted oily dispersion or filter cake that may contain waxes and other non- cannabinoid impurities that were present in the extract can be dumped in its entirety. Alternatively the oil can be recycled to be used again in step a) of the process of the first aspect of the invention.
  • Another aspect of the invention relates to a process for obtaining a cannabinoid product, comprising the steps of obtaining a cannabinoid extract according to the first aspect of the invention; and adding one or more flavours or aromas to said extract.
  • the cannabinoid product has superior characteristics compared to existing cannabinoid products. Suitable products may be in the form of food grade products such as cooking oil or dairy butter or pharmaceutical product or inhalation products. Depending on the desired product, any suitable carrier or agent may be added to provide the desired characteristics.
  • the extract may serve suitably as a base product which can suitably be adapted in composition, e.g. by the addition of flavours or aromas, to meet the wishes of users.
  • terpene profile comprising one or more terpenes may be added to provide a product with a natural and appealing flavour or odour.
  • Terpenes are organic compounds that affect the aroma and flavour profile of cannabis products.
  • Non-limiting examples of terpenes that are present in Cannabis plants include limonene, which confers a citrus flavour/aroma; myrcene, which confers an earthy and musky flavour/aroma; linalool, which confers a floral flavour/aroma with a hint of spice; pinene which confers a pine flavour/aroma; caryophyllene which confers a hoppy flavour/aroma; humulene which confers a sweet flavour/aroma and valencene which confers a citrus flavour /aroma .
  • the process for obtaining a cannabinoid product as described herein comprises extracting and separating one or more terpenes from the oily dispersion as defined in respect of the first aspect of the invention, and adding at least a portion of said one or more terpenes to the cannabinoid extract.
  • the inventor has also found that the above described processes can also be applied to isolate fragrances and flavours from hop plants, by providing a dispersion of material from one or more hop plants in an oil; and isolating at least a portion of fragrances and/or flavours from said dispersion to obtain an extract comprising fragrances and/or flavours.
  • the flask was connected to the vacuum system which comprised a splash bulb, a primary surface condenser that was kept at 5°C by a thermostat and that was fitted with a rotating multi-flask receiver, a dry ice trap kept at -50 °C, a mechanical vacuum pump and a vacuum gauge.
  • the contents of the flask were heated to 100°C.
  • To provide agitation sparging water was heated to 100°C and introduced below the surface of the oil at a rate of approximately 100 mL/h for a period of approximately 30 minutes. This caused mostly terpenes like pinene, limonene, myrcene and linalool to be stripped out of the oil. They were condensed and collected into the receiving flask underneath the primary condenser.
  • the temperature of the suspension was raised to 150°C, which caused the cannabinoic acids to decarboxylate and liberate carbon dioxide.
  • a further fraction comprising heavier sesquiterpenes like caryophyllene, humulene and valencene was collected into the same receiving flask under the primary condenser.
  • the combined condensate will be referred to as the 'light fraction'.
  • By raising the temperature to just below 200°C further material was stripped out of the suspension and collected in a separate flask. This fraction has an unpleasant taste and had therefore to be kept separate so that it could be discarded. Both light fractions were isolated from the system by closing a valve an removed before proceeding.
  • cannabinoids By raising the temperature to 200-210°C and continuing stripping by the introducing water at a rate of 100 mL/h cannabinoids started to be extracted from the suspension and continued to do so when the temperature was raised stepwise to 220°C, 230°C and finally 240°C at 30 minute intervals.
  • the surface condenser was kept in the range of 60-80°C so the viscous condensate could easily drip into the receiving flask. Most of the stripping steam passed into the cold trap where it froze. After the suspension had been stripped for 30 minutes at the final temperature, the heating was switched off and when the suspension had cooled down, vacuum was broken and samples were taken for analysis.
  • the cannabinoid content of this oil sample was determined by isocratic HPLC using a silica column and methanol as solvent. Analysis showed the residual cannabinoid content of the oil to equal 0.63 wt%. This means that the oil still contained some 14 g of cannabinoids, which is a low figure in comparison with the 50-100 g that was introduced into the oil, and which implies isolation yields from fresh Cannabis flowers and trichome covered leaves of up to 86% and more. This figure could have been lowered by continuing the experiment but since the oil had hardly degraded during the steam stripping process, it could also have been used for a subsequent batch after solids removal. That way, the cannabinoids present in the oil would have been subjected to a subsequent steam stripping process and because their concentration had been increased by the dissolution of the next batch of Cannabis plant material, their volatility and rate of vaporisation would also have been increased.
  • the experiment also illustrates that the process according to the invention allows the cannabinoids to be decarboxylated during their isolation.
  • Analysis of the cannabinoid distillate fraction showed it to contain only 0.92% ⁇ -9 tetrahydrocannabinol acid as opposed to 38.41 % ⁇ -9 tetrahydrocannabinol, thus demonstrating extensive decarboxylation .
  • the example also illustrates that the process according to the invention allows of successive collection of volatiles. It enables separate collection of a light fraction comprising terpenes and sesquiterpenes, an undesirable fraction, which the process according to the invention permits to be collected separately and to be discarded and finally the cannabinoid fraction.
  • a Cannabis plant extract containing 54 wt % cannabinoids was purchased on the open market.
  • An aliquot was dissolved in vegetable oil and introduced into a 500 mL flask that was provided with a steam supply.
  • the oil was heated to 250°C and stripped with steam at a pressure of ⁇ 1 mbar for 2 hours.
  • the steam was supplied as water heated to 100°C at a rate of 4 wt% of the oil per hour .
  • the ethanol has extracted the cannabinoids from the oil in a seemingly quantitative manner.
  • the process according to the invention allows cannabinoids to be isolated in a really simple manner with high extraction yields.
  • cannabinoids By suspending the Cannabis plant material in oil, cannabinoids will be extracted but other oil-soluble compounds such as waxes and triglyceride oils will also be extracted by this oil. These oil-soluble compounds are not soluble in alcohol and can thus be separated from the cannabinoids by alcohol extraction .

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Extraction Or Liquid Replacement (AREA)
  • Fats And Perfumes (AREA)
PCT/EP2018/073392 2017-09-12 2018-08-30 METHODS FOR ISOLATING AN EXTRACT OF CANNABINOID AND A PRODUCT FROM CANNABIS PLANT MATERIAL WO2019052830A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA3075323A CA3075323A1 (en) 2017-09-12 2018-08-30 Processes for the isolation of a cannabinoid extract and product from cannabis plant material

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17306175.5A EP3453397A1 (de) 2017-09-12 2017-09-12 Verfahren zur isolierung eines cannabinoidextrakts und produkt aus cannabispflanzenmaterial
EP17306175.5 2017-09-12

Publications (1)

Publication Number Publication Date
WO2019052830A1 true WO2019052830A1 (en) 2019-03-21

Family

ID=60888302

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2018/073392 WO2019052830A1 (en) 2017-09-12 2018-08-30 METHODS FOR ISOLATING AN EXTRACT OF CANNABINOID AND A PRODUCT FROM CANNABIS PLANT MATERIAL

Country Status (4)

Country Link
US (1) US10428040B2 (de)
EP (1) EP3453397A1 (de)
CA (1) CA3075323A1 (de)
WO (1) WO2019052830A1 (de)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020211562A1 (zh) * 2019-04-15 2020-10-22 云南汉盟制药有限公司 一种从大麻中提取挥发油的方法及挥发油的应用
US11040932B2 (en) 2018-10-10 2021-06-22 Treehouse Biotech, Inc. Synthesis of cannabigerol
US11084770B2 (en) 2016-12-07 2021-08-10 Treehouse Biotech, Inc. Cannabis extracts
US11202771B2 (en) 2018-01-31 2021-12-21 Treehouse Biotech, Inc. Hemp powder

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015049585A2 (en) 2013-10-04 2015-04-09 Natural Extraction Services, Llc Method and apparatus for extracting botanical oils
US10822320B2 (en) 2018-08-10 2020-11-03 Natural Extraction Systems, LLC Methods to purify cannabinoids
US10669248B2 (en) 2018-08-10 2020-06-02 Natural Extraction Systems, LLC Methods to chemically modify cannabinoids
EP3946399A1 (de) 2019-03-28 2022-02-09 Apeks, LLC Anlage und verfahren zur kontinuierlichen verarbeitung von pflanzenmaterial
CN111838746B (zh) * 2019-04-30 2022-04-05 云南汉盟制药有限公司 一种香烟爆珠及其制备方法和香烟
US10717056B1 (en) 2019-09-09 2020-07-21 Michael Cem Gokay Method and apparatus for purification of cannabinoid extracts
US11078176B2 (en) * 2019-09-30 2021-08-03 Socati Technologies - Oregon, Llc Pubescent plant shallow moving bed solvent extractor and method of use
CA3157507A1 (en) * 2019-10-10 2021-04-15 Jamaican Brew House A terpene-reduced cannabinoid adjunct
US10765965B1 (en) 2019-12-10 2020-09-08 Loxley Systems, Llc Systems, methods, and equipment for chemical extraction
WO2021118539A1 (en) * 2019-12-10 2021-06-17 Loxley Systems, Llc Systems, methods, and equipment for chemical extraction
US10745644B1 (en) * 2019-12-27 2020-08-18 Cresco Labs Llc Post processing method for cannabis oil
US11813549B1 (en) * 2020-03-04 2023-11-14 Eco-Logic Environmental Engineering Inc. Devices and methods for essential oils, terpenes, flavonoids, and hydrosols extraction
US20210308636A1 (en) * 2020-04-02 2021-10-07 Brian Brown Tetrahydrocannabinol emulsion and method of making and using
US11253793B1 (en) * 2020-12-24 2022-02-22 UCG Holdings, LLC Isolating components from plants
US11779621B2 (en) 2021-12-17 2023-10-10 Jeff Braile System and method for aerobic respiratory treatment

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004026857A2 (en) 2002-09-23 2004-04-01 Gw Pharma Limited Methods of purifying cannabinoids from plant material
US7622140B2 (en) 2001-05-04 2009-11-24 Gw Pharma Limited Processes and apparatus for extraction of active substances and enriched extracts from natural products
CA2872528A1 (en) 2012-05-03 2013-11-07 Echo Pharmaceuticals B.V. Cannabis plant isolate comprising .delta.9-tetrahydrocannabinol and a method for preparing such an isolate
US8895078B2 (en) 2000-10-17 2014-11-25 Bionorica Ethics Gmbh Method for producing an extract from cannabis plant matter, containing a tetrahydrocannabinol and a cannabidiol and cannabis extracts
US20160213720A1 (en) * 2015-01-22 2016-07-28 Rm3 Labs LLC Process for the extraction of cannabinoids from cannabis using lipids as an extraction solvent
US20160326130A1 (en) 2015-05-07 2016-11-10 Axim Biotechnologies, Inc. Process to extract and purify delta-9-tetrahydrocannabinol
US20170008870A1 (en) 2015-07-06 2017-01-12 Clare J. Dibble Methods for Obtaining Purified Cannabis Extracts and THCA Crystals
WO2017026897A1 (en) 2015-08-13 2017-02-16 Bruining Wernard Ernest Extraction device and an extraction method for extraction of cannabis
US9649349B1 (en) * 2017-01-19 2017-05-16 Metamorphic Alchemy & Distillations, Inc. System and method for producing a terpene-enhanced cannibinoid concentrate
WO2017137992A1 (en) * 2016-02-11 2017-08-17 Gelpell Ag Oral solid cannabinoid formulations, methods for producing and using thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU766988B2 (en) 1998-04-21 2003-10-30 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Cannabinoids as antioxidants and neuroprotectants
US20120043242A1 (en) 2010-08-19 2012-02-23 Andrew David Hospodor Medicinal cannabis fatty foodstuff
US8445034B1 (en) 2010-11-02 2013-05-21 Albert L Coles, Jr. Systems and methods for producing organic cannabis tincture
CA2930266A1 (en) * 2013-11-11 2015-05-14 The Werc Shop, LLC Solvent-free processing, system and methods

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8895078B2 (en) 2000-10-17 2014-11-25 Bionorica Ethics Gmbh Method for producing an extract from cannabis plant matter, containing a tetrahydrocannabinol and a cannabidiol and cannabis extracts
US7622140B2 (en) 2001-05-04 2009-11-24 Gw Pharma Limited Processes and apparatus for extraction of active substances and enriched extracts from natural products
WO2004026857A2 (en) 2002-09-23 2004-04-01 Gw Pharma Limited Methods of purifying cannabinoids from plant material
CA2872528A1 (en) 2012-05-03 2013-11-07 Echo Pharmaceuticals B.V. Cannabis plant isolate comprising .delta.9-tetrahydrocannabinol and a method for preparing such an isolate
US20150126754A1 (en) 2012-05-03 2015-05-07 Echo Pharmaceuticals B.V. Cannabis plant isolate comprising delta-9-tetrahydrocannabinol and a method for preparing such an isolate
US20160213720A1 (en) * 2015-01-22 2016-07-28 Rm3 Labs LLC Process for the extraction of cannabinoids from cannabis using lipids as an extraction solvent
US20160326130A1 (en) 2015-05-07 2016-11-10 Axim Biotechnologies, Inc. Process to extract and purify delta-9-tetrahydrocannabinol
US20170008870A1 (en) 2015-07-06 2017-01-12 Clare J. Dibble Methods for Obtaining Purified Cannabis Extracts and THCA Crystals
WO2017026897A1 (en) 2015-08-13 2017-02-16 Bruining Wernard Ernest Extraction device and an extraction method for extraction of cannabis
WO2017137992A1 (en) * 2016-02-11 2017-08-17 Gelpell Ag Oral solid cannabinoid formulations, methods for producing and using thereof
US9649349B1 (en) * 2017-01-19 2017-05-16 Metamorphic Alchemy & Distillations, Inc. System and method for producing a terpene-enhanced cannibinoid concentrate

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CITTI CINZIA ET AL: "Medicinal cannabis: Principal cannabinoids concentration and their stability evaluated by a high performance liquid chromatography coupled to diode array and quadrupole time of flight mass spectrometry method", JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, NEW YORK, NY, US, vol. 128, 31 August 2016 (2016-08-31), pages 201 - 209, XP009504210, ISSN: 0731-7085, DOI: 10.1016/J.JPBA.2016.05.033 *
MORINI LUCA ET AL: "Therapeutic Use of Delta 9-THC and Cannabidiol: Evaluation of a New Extraction Procedure for the Preparation of Cannabis-based Olive Oil", CURRENT PHARMACEUTICAL BIOTECHNOLOGY, BENTHAM SCIENCE PUBLISHERS, NL, vol. 18, no. 10, 1 January 2017 (2017-01-01), pages 828 - 833, XP009504209, ISSN: 1389-2010, DOI: 10.2174/1389201019666171129175655 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11084770B2 (en) 2016-12-07 2021-08-10 Treehouse Biotech, Inc. Cannabis extracts
US11202771B2 (en) 2018-01-31 2021-12-21 Treehouse Biotech, Inc. Hemp powder
US11040932B2 (en) 2018-10-10 2021-06-22 Treehouse Biotech, Inc. Synthesis of cannabigerol
WO2020211562A1 (zh) * 2019-04-15 2020-10-22 云南汉盟制药有限公司 一种从大麻中提取挥发油的方法及挥发油的应用

Also Published As

Publication number Publication date
US20190077781A1 (en) 2019-03-14
US10428040B2 (en) 2019-10-01
CA3075323A1 (en) 2019-03-21
EP3453397A1 (de) 2019-03-13

Similar Documents

Publication Publication Date Title
US10428040B2 (en) Processes for the isolation of a cannabinoid extract and product from Cannabis plant material
US11135258B2 (en) Method for preparation of pharmacologically-relevant compounds from botanical sources
US10888595B2 (en) Apparatus for preparation of pharmacologically-relevant compounds from botanical sources
US11248189B2 (en) Apparatus and method for plant extraction
US5512285A (en) Fragrance extraction
Starmans et al. Extraction of secondary metabolites from plant material: a review
US10967018B2 (en) Methods for extraction and isolation of isoprenoid and terpene compounds from biological extracts
US20190232190A1 (en) Method and apparatus for preparation of pharmacologically-relevant compounds from botanical sources
US20230381684A1 (en) Method and apparatus for dehydration and decarboxylation of cannabis
KR20030059226A (ko) 용매추출방법
CA3000255A1 (en) Method of continuous extraction and separation of useful compounds from plant or animal material
US7615241B2 (en) Vapor scrubbing process and apparatus
JP6052556B2 (ja) 従来溶剤の代替溶剤によって臭気抽出物を抽出する方法
Rout et al. Comparison of extraction methods of Mimusops elengi L. flowers
US10625176B2 (en) Method for continuous extraction and separation of useful compounds for plant or animal material
WO2000064555A2 (en) Solvent extraction process
WO2020191098A1 (en) Method of producing purified cannabis extracts
Kristiawan et al. Isolation of Indonesian cananga oil by instantaneous controlled pressure drop
US5641489A (en) Extracting maltol and water from naturally occurring plant material containing maltol and water
WO2022020942A1 (en) Methods and systems for the selective extraction of phytochemicals

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18759331

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 3075323

Country of ref document: CA

NENP Non-entry into the national phase

Ref country code: DE

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 11-08-2020)

122 Ep: pct application non-entry in european phase

Ref document number: 18759331

Country of ref document: EP

Kind code of ref document: A1